Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.
Edwards KR, Schmidt K, Homad LJ, Kher GM, Xu G, Rodrigues KA, Ben-Akiva E, Abbott J, Prlic M, Newell EW, De Rosa SC, Irvine DJ, Pancera M, McGuire AT.
Edwards KR, et al. Among authors: schmidt k.
Cell Rep Med. 2024 May 16:101587. doi: 10.1016/j.xcrm.2024.101587. Online ahead of print.
Cell Rep Med. 2024.
PMID: 38781964
Free article.